Raising Quality, Improving Lives
The company’s solutions are designed to extend the benefits of radiation oncology to more patients and enable noninvasive treatments that allow patients to return to living fuller lives more quickly and less painfully after receiving a cancer diagnosis.
Xcision’s initial focus is on breast cancer, using stereotactic partial breast irradiation to treat patients eligible for breast conserving therapy. The company’s first product, GammaPod™, is a new stereotactic radiotherapy system optimized for the treatment of breast cancer in one to five sessions. The system has been developed based on a patent from the University of Maryland.
Location: United States, Maryland, Columbia
Employees: 11-50
Phone: +1 443-917-2373
Founded date: 2006
Investors 2
| Date | Name | Website |
| - | Button Cap... | buttoninve... |
| 01.04.2022 | UM Venture... | umventures... |
Mentions in press and media 4
| Date | Title | Description | Source |
| 25.04.2024 | Xcision to feature GammaPod - a powerful tool for breast can... | Xcision's GammaPod technology for early stage breast cancer Xcision Medical Systems, LLC, a medical ... | prweb.com/... |
| 19.09.2022 | Vera Bradley Foundation for Breast Cancer Classic Event Rais... | FORT WAYNE, Ind., Sept. 19, 2022 (GLOBE NEWSWIRE) -- The Vera Bradley Foundation for Breast Cancer (... | globenewsw... |
| 12.04.2022 | Xcision Announces Start of Breast Cancer Treatments Using Ga... | GammaPod™ Stereotactic Radiotherapy System, a breast cancer treatment system “GammaPod will allow us... | prweb.com/... |
| 08.01.2018 | Maryland-made breast cancer treatment system gets FDA cleara... | After nearly a decade in development, a device to treat breast cancer that was developed at the Univ... | technical.... |